EFFECTS OF SPIRONOLACTONE IN PATIENTS WITH HEART FAILURE ACROSS THE SPECTRUM OF KIDNEY RISK IN TOPCAT AMERICAS

被引：0
|
作者：
Chatur, Safia [1 ]
Beldhuis, Iris [1 ]
Neuen, Brendon [1 ]
Claggett, Brian [1 ]
Desai, Akshay S. [1 ]
Lewis, Eldrin F. [1 ]
Anand, Inderjit S. [1 ]
Shah, Sanjiv Jayendra [1 ]
Sweitzer, Nancy K. [1 ]
Fang, James C. [1 ]
Pitt, Bertram [1 ]
Pfeffer, Marc A. [1 ]
Vaduganathan, Muthiah [1 ]
Solomon, Scott D. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1051-07
引用
收藏
页码：330 / 330
页数：1
相关论文
共 50 条
  • [41] Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the spironolactone for heart failure with preserved ejection fraction (TOPCAT) trial
    De Marco, C.
    Claggett, B.
    De Denus, S.
    Huynh, T.
    Desai, A. S.
    Sirois, M. G.
    Jarolim, P.
    Solomon, S. D.
    Pitt, B.
    Rouleau, J. L.
    Pfeffer, M. A.
    O'meara, E.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3952 - 3952
  • [42] Ischemic risk in patients with heart failure with preserved ejection fraction: A post hoc analysis of the TOPCAT data
    He, Xin
    Dong, Bin
    Liang, Weihao
    Wu, Yuzhong
    Chen, Yili
    Dong, Yugang
    He, Jiangui
    Liu, Chen
    ATHEROSCLEROSIS, 2022, 344 : 1 - 6
  • [43] Prognostic Value of Baseline BNP and NT-ProBNP and its Interaction With Spironolactone in Patients With Heart Failure and Preserved Ejection Fraction in the TOPCAT Trial
    Anand, Inder S.
    Solomon, Scott D.
    Claggett, Brian
    Shah, Sanjiv J.
    O'Meara, Eileen
    Boineau, Robin
    Fleg, Jerome L.
    Pfeffer, Marc A.
    Pitt, Bertram
    CIRCULATION, 2015, 132
  • [44] Predictors of Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Systolic Function: A Topcat Americas Post Hoc Analysis
    Saksena, Sanjeev
    Slee, April
    Lakkireddy, Dhanunjaya
    Shah, Dipen
    Di Biase, Luigi
    Lewalter, Thorsten
    Natale, Andrea
    CIRCULATION, 2020, 142
  • [45] Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum
    Butler, Javed
    Usman, Muhammad Shariq
    Anstrom, Kevin J.
    Blaustein, Robert O.
    Bonaca, Marc P.
    Ezekowitz, Justin A.
    Freitas, Cecilia
    Lam, Carolyn S. P.
    Lewis, Eldrin F.
    Lindenfeld, JoAnn
    McMullan, Ciaran J.
    Mentz, Robert J.
    O'Connor, Christopher
    Rosano, Giuseppe M. C.
    Ines Saldarriaga, Clara
    Senni, Michele
    Udelson, James
    Voors, Adriaan A.
    Zannad, Faiez
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (11) : 2029 - 2036
  • [46] METABOLIC EFFECTS OF DAPAGLIFLOZIN IN HEART FAILURE ACROSS THE SPECTRUM OF EJECTION FRACTION
    Selvaraj, Senthil
    Patel, Shachi
    Sauer, Andrew
    McGarrah, Robert
    Jones, Philip
    Kwee, Lydia
    Windsor, Sheryl L.
    Ilkayeva, Olga
    Muehlbauer, Michael
    Newgard, Christopher B.
    Borlaug, Barry
    Kitzman, Dalane W.
    Shah, Sanjiv Jayendra
    Margulies, Kenneth B.
    Husain, Mansoor
    Inzucchi, Silvio E.
    McGuire, Darren K.
    Lanfear, David E.
    Javaheri, Ali
    Umpierrez, Guillermo
    Mentz, Robert John
    Sharma, Kavita
    Kosiborod, Mikhail
    Shah, Svati
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 317 - 317
  • [47] Fracture risk in men with congestive heart failure - Risk reduction with spironolactone
    Carbone, Laura D.
    Cross, Jessica D.
    Raza, Syed H.
    Bush, Andrew J.
    Sepanski, Robert J.
    Dhawan, Saurabh
    Khan, Bilal Q.
    Gupta, Malini
    Ahmad, Khurram
    Khouzam, Rami N.
    Dishmon, Dwight A.
    Nesheiwat, Joseph P.
    Hajjar, Mohammad A.
    Chishti, Waqas A.
    Nasser, Wael
    Khan, Mehwish
    Womack, Catherine R.
    Cho, Tara
    Haskin, Ashley R.
    Weber, Karl T.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (02) : 135 - 138
  • [48] Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial)
    Ferreira, Joao Pedro
    Cleland, John G. F.
    Girerd, Nicolas
    Pellicori, Pierpaolo
    Hazebroek, Mark R.
    Verdonschot, Job
    Collier, Timothy J.
    Petutschnigg, Johannes
    Clark, Andrew L.
    Staessen, Jan A.
    Heymans, Stephane
    Rossignol, Patrick
    Zannad, Faiez
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 191 : 39 - 42
  • [49] Autonomic Effects of Spironolactone and MR Blockers in Heart Failure
    Justine I. Davies
    Miles D. Witham
    Allan D. Struthers
    Heart Failure Reviews, 2005, 10 : 63 - 69
  • [50] Autonomic effects of spironolactone and MR blockers in heart failure
    Davies, JI
    Witham, MD
    Struthers, AD
    HEART FAILURE REVIEWS, 2005, 10 (01) : 63 - 69
12345